Skip to main content
SpringerLink
Log in
Book cover

DGIM Innere Medizin pp 1–12Cite as

MODY

  • Living reference work entry
  • Latest version View entry history
  • First Online:

  • 103 Accesses

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Beim „maturity onset diabetes of the young“ (MODY) handelt es sich um eine heterogene Gruppe von monogenetisch vererbten Diabetesformen. Die Verläufe können sehr variabel sein, zum Teil auch lange klinisch unentdeckt bleiben. Eine Abgrenzung zu den sehr viel häufigeren Diabetesformen Typ 1 und Typ 2 ist für die betroffenen Patienten wichtig, da sich sowohl die Therapie als auch die Prognose wesentlich unterscheiden können.

This is a preview of subscription content, log in via an institution.

Literatur

  • Ahluwalia R, Perkins K et al (2009) Exenatide-a potential role in treatment of HNF1-alpha MODY in obese patients? Diabet Med 26(8):834–835

    Article  CAS  Google Scholar 

  • Ang SF, Lim SC, Tan CSH, Fong JCW, Kon WYC, Lian JX, Subramanium T, Sum CF (2016) A preliminary study to evaluate the strategy of combining clinical criteria and next generation sequencing (NGS) for the identification of monogenic diabetes among multi-ethnic Asians. Diabetes Res Clin Pract 119:13–22. https://doi.org/10.1016/j.diabres.2016.06.008

    Article  CAS  PubMed  Google Scholar 

  • Awa WL, Thon A et al (2011) Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database. Eur J Endocrinol 164(4):513–520

    Article  CAS  Google Scholar 

  • Bacq Y, Jacquemin E et al (2003) Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology 125(5):1470–1475

    Article  Google Scholar 

  • Bellanné-Chantelot C, Coste J, Ciangura C, Fonfrède M, Saint-Martin C, Bouché C, Sonnet E, Valéro R, Lévy DJ, Dubois-Laforgue D, Timsit J (2016) Monogenic Diabetes Study Group of the Société Francophone du Diabète (SFD). High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A-MODY and familial young-onset type 2 diabetes: a grey zone analysis. Diabetes Metab 42(1):33–37. https://doi.org/10.1016/j.diabet.2015.02.001. Epub 2015 Mar 6

    Article  CAS  PubMed  Google Scholar 

  • Besser RE, Shepherd MH et al (2011) Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 34(2):286–291

    Article  CAS  Google Scholar 

  • Bluteau O, Jeannot E et al (2002) Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 32(2):312–315

    Article  CAS  Google Scholar 

  • Butte NF, Hopkinson JM et al (1999) Adjustments in energy expenditure and substrate utilization during late pregnancy and lactation. Am J Clin Nutr 69(2):299–307

    Article  CAS  Google Scholar 

  • Chen L, Magliano DJ et al (2012) The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol 8(4):228–236

    Article  CAS  Google Scholar 

  • Fajans SS, Bell GI (2006) Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees. Diabetologia 49(5):1106–1108

    Article  CAS  Google Scholar 

  • Fajans SS, Bell GI (2011) MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 34(8):1878–1884

    Article  Google Scholar 

  • Firdous P, Nissar K, Ali S, Ganai BA, Shabir U, Hassan T, Masoodi SR (2018) Genetic testing of maturity-onset diabetes of the young current status and future perspectives. Front Endocrinol (Lausanne) 9:253. https://doi.org/10.3389/fendo.2018.00253. eCollection 2018. Review. PubMed PMID: 29867778; PubMedCentral PMCID: PMC5966560

    Article  Google Scholar 

  • Gat-Yablonski G, Shalitin S et al (2006) Maturity onset diabetes of the young–review. Pediatr Endocrinol Rev 3(3):514–520

    PubMed  Google Scholar 

  • Genuth S, Alberti KG et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160–3167

    Article  Google Scholar 

  • Gupta RK, Vatamaniuk MZ et al (2005) The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J Clin Invest 115(4):1006–1015

    Article  CAS  Google Scholar 

  • Hansen T, Eiberg H et al (1997) Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes 46(4):726–730

    Article  CAS  Google Scholar 

  • Iwen KA, Klein J et al (2013) Maturity-onset diabetes of the young and hepatic adenomatosis – characterisation of a new mutation. Exp Clin Endocrinol Diabetes 121(6):368–371

    Article  CAS  Google Scholar 

  • Kerner W, Brückel J (2011) Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetol Stoffwechsel 6(S 02):107–110

    Article  Google Scholar 

  • Lorini R, Klersy C et al (2009) Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. Diabetes Care 32(10):1864–1866

    Article  CAS  Google Scholar 

  • Lumb AN, Gallen IW (2009) Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin(1). Diabet Med 26(2):189–190

    Article  Google Scholar 

  • McDonald TJ, Colclough K et al (2011) Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med 28(9):1028–1033

    Article  CAS  Google Scholar 

  • Misra S, Owen KR (2018) Genetics of monogenic diabetes: present clinical challenges. Curr Diab Rep 18(12):141. https://doi.org/10.1007/s11892-018-1111-4. Review. PubMed PMID: 30377832; PubMed Central PMCID: PMC6209016

    Article  PubMed  PubMed Central  Google Scholar 

  • Mughal SA, Park R, Nowak N, Gloyn AL, Karpe F, Matile H, Malecki MT, McCarthy MI, Stoffel M, Owen KR (2013) Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes. Diabet Med 30(2):246–250. https://doi.org/10.1111/dme.12066. PubMed PMID:23157689; PubMed Central PMCID: PMC4193536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Naylor R, Philipson LH (2011) Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol 75(4):422–426

    Article  Google Scholar 

  • Online Mendelian Inheritance in Man (OMIM) Datenbank. http://omim.org/entry/606391. Zugegriffen am 20.10.2014

  • Reznik Y, Dao T et al (2004) Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 89(3):1476–1480

    Article  CAS  Google Scholar 

  • Shields BM, Hicks S et al (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53(12):2504–2508

    Article  CAS  Google Scholar 

  • Shields BM, McDonald TJ et al (2012) The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55(5):1265–1272

    Article  CAS  Google Scholar 

  • Shields BM, Shepherd M, Hudson M, McDonald TJ, Colclough K, Peters J et al (2017) Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients. Diabetes Care 40(8):1017–1025. https://doi.org/10.2337/dc17-0224

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stride A, Shepherd M et al (2002a) Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers. Diabetes Care 25(12):2287–2291

    Article  CAS  Google Scholar 

  • Stride A, Vaxillaire M et al (2002b) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45(3):427–435

    Article  CAS  Google Scholar 

  • Stride A, Ellard S et al (2005) Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 28(7):1751–1756

    Article  CAS  Google Scholar 

  • Thanabalasingham G, Owen KR (2011) Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 343:6044

    Article  Google Scholar 

  • Thanabalasingham G, Shah N et al (2011) A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 54(11):2801–2810

    Article  CAS  Google Scholar 

  • Vaxillaire M, Froguel P (2008) Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 29(3):254–264

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Schleswig-Holstein, Medizinische Klinik I, Lübeck, Deutschland

    K. Alexander Iwen

  2. Praxis Diabetes plus, Lübeck, Deutschland

    Morten Schütt

Authors
  1. K. Alexander Iwen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morten Schütt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Alexander Iwen .

Editor information

Editors and Affiliations

  1. Medizinische Klinik I, Universitätsklinikum Schleswig-Hoslstein, Campus Lübeck, Lübeck, Schleswig-Holstein, Germany

    Hendrik Lehnert

Section Editor information

  1. TU Dresden Universitätsklinikum Carl Gustav Carus, Dresden, Germany

    Sebastian M. Schellong

  2. FB Gastroenterologie und Hepatologie, Universitätsklinikum Leipzig Medizinische Klinik und Poliklinik II, Leipzig, Sachsen, Germany

    Joachim Mössner

  3. Krankenhaus Barmherzige Brüder, Regensburg, Germany

    Cornel C. Sieber

  4. Nürnberg, Bayern, Germany

    Walter Swoboda

  5. Universitätsklinikum Giessen und Marburg Klinik für Innere Medizin, Marburg, Hessen, Germany

    Andreas Neubauer

  6. Interdisziplinärer Schwerpunkt für Hämos, Universitätsklinikum Gießen und Marburg, Gießen, Germany

    Bettina Kemkes-Matthes

  7. Klinik für Gastroenterologie,Hepatologie, Medizinische Hochschule Hannover, Hannover, Germany

    Michael P. Manns

  8. Sektion für Molekulare und Klinische Inf, Universitätsklinikum Schleswig-Holstein,, Lübeck, Germany

    Jan Rupp

  9. Abt. Kardiologie und Pneumologie, Universitätsklinikum Göttingen Herzzentrum Göttingen, Göttingen, Germany

    Gerd Hasenfuß

  10. Abt. Nephrologie und Klinische Immunologie, Univ.Klinikum Aachen Medizinische Klinik II, Aachen, Germany

    J. Floege

  11. Universitätsklinikum Köln Klinik I für Innere Medizin, Köln, Germany

    Michael Hallek

  12. Klinik für Pneumologie, Medizinische Hochschule Hannover (MHH) Zentrum Innere Medizin, Hannover, Germany

    Tobias Welte

  13. Klinik u. Poliklinik für Innere Medizin, Universitätsmedizin Greifswald, Greifswald, Germany

    Markus Lerch

  14. Dr.-Horst-Schmidt-Kliniken GmbH, Wiesbaden, Germany

    Elisabeth Märker-Hermann

  15. Klinische Toxikologie, Giftinformation, Universitätsklinikum Mainz II. Medizinische Klinik und Poliklinik, Mainz, Germany

    Ludwig Sacha Weilemann

  16. Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland

    Hendrik Lehnert

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Iwen, K.A., Schütt, M. (2020). MODY. In: Lehnert, H. (eds) DGIM Innere Medizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54676-1_5-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54676-1_5-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54676-1

  • Online ISBN: 978-3-642-54676-1

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Chapter history

  1. Latest

    MODY
    Published:
    15 February 2020

    DOI: https://doi.org/10.1007/978-3-642-54676-1_5-2

  2. Original

    MODY
    Published:
    16 December 2014

    DOI: https://doi.org/10.1007/978-3-642-54676-1_5-1

Search

Navigation